Addition/Correction www.acsami.org
Cite This: ACS Appl. Mater. Interfaces XXXX, XXX, XXX−XXX
Correction to “Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy” Song Yi Lee, Seung-Hak Ko, Jae-Seong Shim, Dae-Duk Kim, and Hyun-Jong Cho*
Downloaded via 91.243.91.151 on December 9, 2018 at 00:58:05 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.
ACS Appl. Mater. Interfaces 2018, 10 (43), 36628−36640. DOI: 10.1021/acsami.8b08243 Regression line of weight ratio (MbCD/HACE)-dependent ratio of integration area (5.0/1.8 ppm) (Figure S1); ex vivo NIRF images of dissected liver, heart, lung, spleen, kidney, and tumor at 24 h post injection (Figure S2); quantitative analysis data of DAB intensity shown in TUNEL assay (Figure S3). The errors occurred during the production process. We apologize for any confusion caused by these errors.
The chemical structure of MbCD (searched by ChemDraw) in the published paper should be changed to more general form (as provided by the manufacturer) (Figures 1 and 2). As the chemical structure of MbCD was not precisely determined, it was changed to show an R group (H or −CH3). The captions were not altered. The caption of Figure S3 was omitted in the Supporting Information list. The description in the paper should read as follows:
Figure 1. Schematic illustration regarding tumor targeting and therapeutic strategy of HACE-MbCD NA.
© XXXX American Chemical Society
A
DOI: 10.1021/acsami.8b19910 ACS Appl. Mater. Interfaces XXXX, XXX, XXX−XXX
ACS Applied Materials & Interfaces
Addition/Correction
Figure 2. Synthesis and identification of HACE-MbCD. (A) Synthetic scheme of HACE-MbCD. The hydroxyl group of MbCD is used for esterification reaction with the carboxylic acid group of HA. (B) 1H NMR spectrum of HACE-MbCD. The chemical shifts “1” (1.8 ppm) and “2” (5.0 ppm) indicate HA and MbCD groups, respectively. For 1H NMR (500 MHz) analysis, HACE-MbCD was solubilized in the mixture of DMSO-d6 and D2O mixture (1:1, v/v).
B
DOI: 10.1021/acsami.8b19910 ACS Appl. Mater. Interfaces XXXX, XXX, XXX−XXX
